EDITORIAL
Why is SARS-CoV-2 infection milder among children?
Patricia PalmeiraI, José Alexandre M BarbutoII, Clovis Artur A SilvaIII, Magda Carneiro-SampaioI,III,
Corresponding author
I Laboratorio de Investigacao Medica (LIM-36), Departamento de Pediatria, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR
II Departamento Imunologia, Instituto de Ciencias Biomedicas, Universidade de Sao Paulo, Sao Paulo, SP, BR
III Departamento de Pediatria, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, BR
Read
1654
Timeswas read the article
493
Total PDF
1161
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 14 | 12 | 26 |
| 2025 11 | 42 | 49 | 91 |
| 2025 10 | 36 | 12 | 48 |
| 2025 9 | 29 | 16 | 45 |
| 2025 8 | 39 | 8 | 47 |
| 2025 7 | 75 | 13 | 88 |
| 2025 6 | 51 | 4 | 55 |
| 2025 5 | 31 | 3 | 34 |
| 2025 4 | 22 | 3 | 25 |
| 2025 3 | 53 | 5 | 58 |
| 2025 2 | 30 | 2 | 32 |
| 2025 1 | 51 | 5 | 56 |
| 2024 12 | 25 | 3 | 28 |
| 2024 11 | 62 | 16 | 78 |
| 2024 10 | 34 | 18 | 52 |
| 2024 9 | 27 | 20 | 47 |
| 2024 8 | 38 | 26 | 64 |
| 2024 7 | 47 | 19 | 66 |
| 2024 6 | 30 | 19 | 49 |
| 2024 5 | 41 | 18 | 59 |
| 2024 4 | 45 | 21 | 66 |
| 2024 3 | 41 | 19 | 60 |
| 2024 2 | 67 | 17 | 84 |
| 2024 1 | 18 | 16 | 34 |
| 2023 12 | 13 | 17 | 30 |
| 2023 11 | 27 | 20 | 47 |
| 2023 10 | 57 | 31 | 88 |
| 2023 9 | 45 | 24 | 69 |
| 2023 8 | 29 | 4 | 33 |
| 2023 7 | 15 | 19 | 34 |
| 2023 6 | 13 | 15 | 28 |
| 2023 5 | 2 | 1 | 3 |
| 2023 4 | 1 | 1 | 2 |
| 2023 3 | 3 | 5 | 8 |
| 2023 2 | 0 | 11 | 11 |
| 2023 1 | 1 | 0 | 1 |
| 2022 12 | 6 | 1 | 7 |
| 2022 11 | 1 | 0 | 1 |
Show all